Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-18-037166

Options or other derivatives

  • Senior Vice President and CFO acquired 235,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-12-20 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +235,000 235,000 D
Loading xslF345X03/form4.xml…